Fuji Keizai Estimates Japan’s Generic Drug Market To Grow 17.5 percent In 2010
This article was originally published in PharmAsia News
Executive Summary
Tokyo based market research company Fuji Keizai estimated the generic drug market in Japan will grow by 17.5 percent to ¥359.7 billion in 2010. Generic drugs will account for 5.2 percent of the prescription drug market. Reasons cited by the company include increased promotion in generic drug prescriptions among national hospitals, implementation of a diagnostic procedure combined payment system and the change in prescription forms. Fuji further noted that due to the expansion of DPC system, the use of generic injection products are increasing and the upward trend will continue. In terms of drug categories, Fuji estimates that hypertension, schizophrenia and diabetic drugs are among the generics that will grow the fastest. (Click here for more - Japanese language